Weekly TOP Startup / VC news of July 24, 2025

Timeplast created a plastic that dissolves in water, leaving no waste. Their tech could revolutionize the $1.3T plastic industry. That’s why 7,000+ people have already invested, and you have only a few days left to join them. Invest in Timeplast by July 31 at midnight.

Invest in Timeplast now.

_{This is a paid advertisement for Timeplast’s Regulation CF Offering. Please read the offering circular at invest.timeplast.com.}

Enterprises worldwide acknowledge Artificial Intelligence as a growth driver. However, many remain unprepared for deep AI integration. A recent Australian survey highlights this significant adoption gap. Despite widespread ambition, most companies lack clear AI strategies, data governance, and ethical frameworks. Yet, focused AI solutions are rapidly gaining traction. Innovations in heavy industry and healthcare demonstrate AI's tangible benefits. New funding rounds underscore market confidence in specialized AI agents. This shift from theoretical promise to practical application defines the current AI landscape. Businesses must move beyond planning. Strategic AI adoption is paramount for future success.

Key funding rounds bolster vital sectors. Deeptech firm BQP secured $5 million. This seed capital fuels its quantum-powered digital twin platform, BQPhy. BQPhy serves aerospace, defense, and semiconductor industries. It promises simulation breakthroughs. Concurrently, B2B packaging innovator DCGpac raised $1.74 million in Pre-Series A. This investment supports technology enhancement, international expansion, and new sustainable packaging models. Both companies drive significant market innovation.

BiomEdit, a leading animal health biotechnology firm, announced major advancements. Its pioneering poultry solution, BE-101 (Optavant™), a non-antibiotic treatment for necrotic enteritis in broiler chickens, entered the final USDA conditional licensure phase, aiming for 2026 market entry. The company secured $18.4 million in oversubscribed Series B funding, ensuring commercialization. New executives joined the leadership team. Broader pipeline progress includes a significant methane-reduction platform for cattle and new grants for highly pathogenic avian influenza (HPAI) and human therapeutic research. This propels sustainable livestock production and global health solutions.

Rwazi, a Los Angeles AI innovator, secured $12 million in Series A funding. This significant capital injection powers its advanced decision intelligence platform. The AI copilot aims to eliminate costly gut-instinct decisions. It uses real-time, voluntarily sourced consumer data. This system analyzes billions of behavioral signals. The funding deepens simulation capabilities and expands global data infrastructure. It empowers Fortune 100 companies. They gain unparalleled clarity across marketing, product, and operations. Rwazi enables precise, data-driven strategies. It helps enterprises spot market shifts early. It predicts outcomes. It ensures swift, confident action. This transforms strategic decision-making in volatile markets, driving growth and efficiency.

Wyld Networks initiates a major SEK 17.6 million rights issue. The capital raise targets significant commercial expansion. It will boost global IoT connectivity solutions. An overallotment option could secure an additional SEK 4.4 million. This strategic move aims to meet surging demand. It strengthens the company’s market footprint. The fully underwritten offering promises crucial funding. Existing shareholders face potential dilution.

Bonsai, a Chicago-based firm, secured $1.8 million in investment. The funding fuels its first-party marketing intelligence platform. This platform automates profitable growth for brands. It integrates diverse marketing data, offering accurate insights. Features include multi-touch attribution, marketing mix modeling, and budget forecasting. Brands gain full control, optimize ROI, and reduce wasted ad spend. The system connects to over 80 platforms, requiring no cookies or complex coding. Leading brands like 1-800-Flowers and Camping World leverage its power. Bonsai reshapes how companies measure and enhance marketing effectiveness. This investment accelerates its market expansion and development efforts, addressing a critical need for unbiased data in an evolving digital landscape.

Hudle, an Indian sports community platform, secured $2.5 million in Series A funding. This capital injection, led by Sky Impact Capital, propels its mission. Hudle streamlines sports discovery and venue booking. It enhances player experience with new tech features. The platform focuses on booming sports like pickleball and padel. It aims to expand its vast network. This move underscores India's dynamic sports tech growth.

Unify, an AI-native platform, secured $40M in Series B funding led by Battery Ventures. OpenAI Startup Fund and other major investors participated. This significant capital infusion will expand operations and accelerate development. Unify's AI agents transform go-to-market strategies, identifying high-intent prospects and automating outreach. The platform drives pipeline growth, evidenced by 8x revenue increase. It empowers sales teams to close deals more effectively, ushering a new era for GTM efficiency.

Exein secured €70 million. This significant Series C funding fuels global expansion. Crucially, it targets the United States, Japan, Taiwan, and South Korea. Exein also fortifies its established European presence. This move addresses a critical vulnerability: smart devices.

OpenEvidence secured $210M in Series B funding, valuing the leading medical AI platform at $3.5 billion. It simultaneously launched DeepConsult, a revolutionary, free AI agent for all verified U.S. physicians. This platform combats clinician information overload. It delivers real-time, evidence-based answers and comprehensive, AI-driven research reports. OpenEvidence aids high-stakes clinical decisions at the point of care. Its system is HIPAA-compliant. The company uses strategic partnerships with top medical journals like JAMA and NEJM. Over 40% of U.S. doctors use it daily. It supports 8.5 million clinical consultations monthly. This marks a 2,000%+ year-over-year growth. OpenEvidence transforms medical knowledge access. It enhances patient outcomes and reduces physician burnout. AI now supports frontline healthcare like never before.

Keeping up with AI is hard – we get it!

That’s why over 1M professionals read Superhuman AI to stay ahead.

Sign up and start mastering AI

(1) weekly essay breaking down how to think about our rapidly changing world. (5) action steps you can take to help build a better one — for everyone.

Join 10K+ founders staying current on the fundraising landscape w/ recent charts, stories, data, and tips on acquiring capital in the current market.

Clicking our affiliate links may earn us a small commission, which helps us keep this newsletter running and improve it for you.